The United States is set to reveal its annual anti-drug certification decisions regarding countries evaluated for their efforts against drug trafficking, placing Colombia before two potential scenarios. The upcoming decision marks a critical point of definition in the bilateral anti-narcotics relationship between Washington and Bogotá.
Ahead of the announcement, the American Chamber of Commerce (AmCham) in Colombia has warned that the primary challenge for the country will be to tangibly demonstrate effective results in its counternarcotics policies to secure favorable certification from the United States.
In-depth summary · AI, neutral